Article Details
Retrieved on: 2024-04-18 20:19:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Therapies have historically been monoclonal antibody C5 inhibitors such as eculizumab and ravulizumab, but the C3 inhibitor pegcetacoplan was approved ...
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here